| The support of human genetic evidence for approved drug indications MR Nelson, H Tipney, JL Painter, J Shen, P Nicoletti, Y Shen, A Floratos, ... Nature genetics 47 (8), 856-860, 2015 | 1526 | 2015 |
| Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases SJ Reisinger, PB Ryan, DJ O'Hara, GE Powell, JL Painter, EN Pattishall, ... Journal of the American Medical Informatics Association 17 (6), 652-662, 2010 | 126 | 2010 |
| Social media listening for routine post-marketing safety surveillance GE Powell, HA Seifert, T Reblin, PJ Burstein, J Blowers, JA Menius, ... Drug safety 39, 443-454, 2016 | 110 | 2016 |
| Refining the impact of genetic evidence on clinical success EV Minikel, JL Painter, CC Dong, MR Neslon Nature, 2024 | 109 | 2024 |
| Performance of stratified and subgrouped disproportionality analyses in spontaneous databases S Seabroke, G Candore, K Juhlin, N Quarcoo, A Wisniewski, R Arani, ... Drug safety 39, 355-364, 2016 | 63 | 2016 |
| Using social listening data to monitor misuse and nonmedical use of bupropion: a content analysis LS Anderson, HG Bell, M Gilbert, JE Davidson, C Winter, MJ Barratt, ... JMIR Public Health and Surveillance 3 (1), e6174, 2017 | 52 | 2017 |
| Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review B Kompa, JB Hakim, A Palepu, KG Kompa, M Smith, PA Bain, ... Drug Safety 45 (5), 477-491, 2022 | 48 | 2022 |
| A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data D Parks, X Lin, JL Painter, J Cheng, CM Hunt, CF Spraggs, JJ Nelson, ... Pharmacoepidemiology and drug safety 22 (6), 571-578, 2013 | 18 | 2013 |
| Electronically predicting corrective options based on a sensed physiological characteristic T Trygstad, A Menius, JL Painter US Patent App. 14/824,730, 2016 | 17 | 2016 |
| Validation of multivariate outlier detection analyses used to identify potential drug-induced liver injury in clinical trial populations X Lin, D Parks, J Painter, CM Hunt, HA Stirnadel-Farrant, J Cheng, ... Drug safety 35, 865-875, 2012 | 17 | 2012 |
| Construction and annotation of a UMLS/SNOMED-based drug ontology for observational pharmacovigilance GH Merrill, PB Ryan, JL Painter Methods, 2008 | 13 | 2008 |
| Developing crowdsourced training data sets for pharmacovigilance intelligent automation A Gartland, A Bate, JL Painter, TA Casperson, GE Powell Drug Safety 44, 373-382, 2021 | 11 | 2021 |
| Strategies for distributed curation of social media data for safety and pharmacovigilance TA Casperson, JL Painter, J Dietrich Proceedings of the International Conference on Data Science (ICDATA), 118, 2016 | 11 | 2016 |
| An industry perspective on the use of machine learning in drug and vaccine safety JL Painter, R Kassekert, A Bate Frontiers in Drug Safety and Regulation 3, 2023 | 8 | 2023 |
| Predicting breast cancer chemotherapeutic response using a novel tool for microarray data analysis J Cheng, J Greshock, J Painter, X Lin, K Lee, S Zheng, A Menius Journal of integrative bioinformatics 9 (2), 80-87, 2012 | 7 | 2012 |
| Engaging Patients via Online Healthcare Fora: Three Pharmacovigilance Use Cases G Powell, V Kara, JL Painter, L Schifano, E Merico, A Bate Frontiers in Pharmacology 13, 2022 | 5 | 2022 |
| Inter-translation of Biomedical Coding Schemes Using UMLS. JL Painter, KM Kleiner, GH Merrill AAAI Fall Symposium: Semantic Web for Collaborative Knowledge Acquisition …, 2006 | 5 | 2006 |
| Enhancing Drug Safety Documentation Search Capabilities with Large Language Models: A User-Centric Approach JL Painter, O Mahaux, M Vanini, V Kara, C Roshan, M Karwowski, ... 2023 International Conference on Computational Science and Computational …, 2023 | 4 | 2023 |
| Toward automating an inference model on unstructured terminologies: OXMIS case study JL Painter Advances in Computational Biology, 645-651, 2010 | 4 | 2010 |
| Codeslinger: An interactive biomedical ontology browser JL Painter, NL Flowers Conference on Artificial Intelligence in Medicine in Europe, 260-264, 2009 | 4 | 2009 |
Andrew BateGSK, LSHTMOverená e-mailová adresa na: gsk.com